EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting Fatty Acids in Liver Cancer: Molecular Insights and Drug Approaches

Antonio Cigliano iD, Dora Pischedda, Claudio Pandino, Grazia Galleri iD, Diego F Calvisi

Biomolecules · 2026

DOI: 10.3390/biom16020329 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, 2026. Verfasst von Antonio Cigliano und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Saint Camillus International University of Health Sciences, 00131 Rome, Italy. Hauptthemen laut MEDLINE: Fatty Acids, Liver Neoplasms, Carcinoma, Hepatocellular, Antineoplastic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 206 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: italian association cancer research AIRC, PRIN.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary liver cancer (PLC), commonly classified as hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC), is a highly aggressive malignancy with a dismal prognosis. Recent research has highlighted the crucial role of dysregulation of fatty acid metabolism in HCC progression and therapeutic resistance. Here, with a focus primarily on HCC, we review how alterations in the processes involving fatty acids dynamically contribute to the survival, proliferation, and development of the drug resistance of PLC cells. In particular, increased expression of fatty acid transporters, reprogramming of de novo lipogenesis, and altered fatty acid oxidation trigger the upregulation of oncogenic signaling pathways and adaptation to nutrient-deprived conditions inducing the rapid proliferation of PLC cells. Furthermore, fatty acid metabolism influences immune cell function and angiogenesis, thereby shaping the tumor microenvironment and promoting the progression of PLC. This review explores the complex relationship between fatty acid metabolism and the progression of PLC. It discusses future directions regarding the most promising druggable targets and their current status in clinical trials. Furthermore, it examines the advancement of innovative therapeutic strategies and highlights the significant challenges in targeting fatty acid metabolism. Finally, it discusses how precision therapies focused on fatty acid metabolism can be effectively integrated with current treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty AcidsLiver NeoplasmsCarcinoma, HepatocellularAntineoplastic AgentsHumansTumor MicroenvironmentLipid MetabolismMetabolic ReprogrammingAnimalsMolecular Targeted TherapyDrug Resistance, NeoplasmSignal Transduction

Stichwörter der Autor:innen

drug resistanceinnovative therapieslipid metabolismmetabolic reprogrammingpersonalized medicineprimary liver cancertumor microenvironment

Substanzen

Fatty AcidsAntineoplastic Agents

Autor:innen und Institutionen

  • Faculty of Medicine, Saint Camillus International University of Health Sciences, 00131 Rome, Italy.
  • Department of Medicine, Surgery, and Pharmacy, University of Sassari, 07100 Sassari, Italy.
  • Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.

ORCID-Profile: Antonio Cigliano, Grazia Galleri

Förderung

  • italian association cancer research AIRC
  • PRIN

Zitieren

APA

Cigliano, A., Pischedda, D., Pandino, C., Galleri, G., & Calvisi, D. F. (2026). Targeting Fatty Acids in Liver Cancer: Molecular Insights and Drug Approaches. Biomolecules. https://doi.org/10.3390/biom16020329

Vancouver

Cigliano A, Pischedda D, Pandino C, Galleri G, Calvisi DF. Targeting Fatty Acids in Liver Cancer: Molecular Insights and Drug Approaches. Biomolecules. 2026. doi:10.3390/biom16020329

BibTeX
@article{Cigliano2026,
  author = {Cigliano, Antonio and Pischedda, Dora and Pandino, Claudio and Galleri, Grazia and Calvisi, Diego F},
  title = {Targeting Fatty Acids in Liver Cancer: Molecular Insights and Drug Approaches},
  journal = {Biomolecules},
  year = {2026},
  doi = {10.3390/biom16020329}
}
Kostenlos starten →